Circassia Pharmaceuticals's total assets for Q2 2024 were £87.50M, a decrease of -4.37% from the previous quarter. GB:NIOX total liabilities were £5.70M for the fiscal quarter, a -25.97% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.